Abstract: The present application provides elastomeric articles that are able to deliver skin care properties to a person wearing or coming into contact with the article. The articles comprise an elastomeric film a plant stem cell material. The plant stem cell material may be in the form of a bilayer membrane-encapsulated plant stem cell material. The plant stem cell material may be present as a layer or coating on a surface of the elastomeric film. Also provided are methods for the production of the articles.

Abstract: A system for providing an oral care agent includes a first layer containing the oral care agent and a second layer. The first layer can be applied directly to teeth. The second layer can subsequently be applied onto the first layer to inhibit leakage of the oral care agent outwards into the mouth.

Abstract: Compositions and methods are provided for the prevention and treatment of chronic wounds, including, without limitation, pressure ulcers and diabetic ulcers, by transdermal delivery of an agent that increases activity of HIF-1? in the wound.

Abstract: The present invention relates to a crosslinked polyacrylate salt, which has been neutralized by two types of amines: (1) amine groups attached to the polymer backbone of an aminosilicone and (2) water soluble organic amines. The compositions of the present invention can readily swell in water, displaying enhanced thickening, emulsifying, dispersing and producing film with water resistance compared to acrylate based thickener alone. The compositions can be used to formulate a wide variety of ingredients, such as, for example, fatty substances, humectants, solid particles, silicones, organic or inorganic sunscreens, without the need of further neutralizing agents, dispersants or emulsifiers.

Abstract: The present disclosure provides a liquid detergent composition with a coconut-based compound for cleaning, cleansing, lubricating, and combinations thereof, that can also be packaged inside a gable-top carton without any leaking or leaching out of the gable-top carton, when other combinations of compositions, as well as certain environmental factors are also present.

Abstract: The present invention relates to certain microorganisms or mixtures thereof for use in the treatment and/or prevention of inflammation in the oral cavity, in particular for use in the treatment and/or prevention of dental caries and/or periodontal disease. In particular, the present invention relates to microorganisms or mixtures thereof for use as an anti-inflammatory agent in the oral cavity for reducing or inhibiting the release of certain inflammatory factors. Furthermore, the present invention provides oral pharmaceutical compositions, oral care products or products for nutrition or pleasure comprising one or more of the microorganisms as probiotic agents as well as a method of production thereof.

Abstract: Filaments containing a filament-forming material and an additive, such as an ingestible active agent, nonwoven webs, and methods for making such filaments are provided.

Abstract: A disinfectant formulation comprising a poly(2-ethyl-2-oxazoline) and a quaternary ammonium compound or combination of quaternary ammonium compounds is provided. A wipe having a residual biocidal property is also provided. The wipe formulation comprises a substrate comprised of a fibrous material, and the formulation present on or in the substrate. The formulation comprises a poly(2-ethyl-2-oxazoline), a quaternary ammonium compound or combination of quaternary ammonium compounds, a surfactant, water, and an optional fragrance.

Abstract: The invention relates to biomarkers of the skin of children and, in particular, that of infants, having altered expression in the presence of urine. Such markers are particularly advantageous as they allow the skin's response to urine to be monitored. The inventors have developed methods for evaluating the efficacy in vitro of formulations in preventing the harmful effects of urine on a child's skin, using a skin model specifically capable of reproducing the characteristics of children's skin.

Abstract: A composition is described that includes benzoyl peroxide. The composition can be formulated for a leave-in topical application and can be provided in the form of a leave-in foam intended to be applied to the skin. The composition can include: at least one intermediate composition, at least one gas-generating agent, at least one agent that activates the gas-generating agent, and benzoyl peroxide. A kit or a single multicompartment container including such a composition is also described.

Abstract: An oral care mouthpiece (10) is disclosed. The mouthpiece includes a shell (15) having an arch shape corresponding to a dental arch. The shell (15) includes a wall corresponding to facial surfaces of teeth in the dental arch, and a bite plate corresponding (157) to biting surfaces of the teeth. The mouthpiece also includes a wicking layer (19) on an inner surface of the wall. The mouthpiece further includes a filament layer (23) on the wicking layer.

Abstract: Antifibrinolytic agents are administered to a human individual to treat fine lines, wrinkles and overall skin tone of the face and body, as well as inflammation and tissue degradation effects.

Abstract: Compositions and methods are provided for the prevention and treatment of chronic wounds, including, without limitation, pressure ulcers and diabetic ulcers, by transdermal delivery of an agent that increases activity of HIF-1? in the wound.

Abstract: A wound therapy device is disclosed. The wound therapy device may include a housing for covering at least a portion of a wound and for sealing to a body surface of a patient. The housing may also include a liquid collector for retaining liquid therein and a vacuum connection for coupling to a vacuum source. The vacuum connection may be in gaseous communication with the liquid collector. The vacuum connection may be separated from the liquid collector by a liquid barrier.

Abstract: The present invention is directed to antiviral compositions that provide efficacy against non-envelope viruses such as noroviruses. The antiviral compositions comprise an alkyl 2-hydroxycarboxylic acid and an effective amount of a sulfonated surfactant. The composition may be used as a topical on human skin, as a hand sanitizer or as a hard surface cleaning composition.

Abstract: The present invention generally relates to skin care and, in particular, to systems and methods for treating and/or preventing acne. Acne is believed to be caused by a combination of factors, including Propionibacterium acnes bacteria, excess sebum production, and inflammation from the immune response (e.g., in response to P. acnes). Certain aspects of the invention are thus directed to one or more compositions that collectively target these factors, although it should be understood that a single composition may target more than one factor at a time. For instance, in one set of embodiments, a treatment may include a first composition that cleans the skin, a second composition that contains growth inhibitor of P. acnes (e.g., for use during the day), and a third composition that inhibits sebum production (e.g., for use during the night). One or more of these may contain other components, such as anti-inflammatory agents, moisturizers, topical anti-microbial agents (e.g., salicylic acid), or the like.

Abstract: Provided herein are compositions comprising a stable water-in-silicone emulsion, and methods and kits comprising the compositions for treating conditions.

Abstract: Non-woven graft materials for use in specialized surgical procedures such as neurosurgical procedures, methods for making the non-woven graft materials, and methods for repairing tissue such as neurological tissue using the non-woven graft materials are disclosed. More particularly, disclosed are non-woven graft materials including at least two distinct fiber compositions composed of different polymeric materials, methods for making the non-woven graft materials and methods for repairing tissue in an individual in need thereof using the non-woven graft materials.

Abstract: [Problem] To provide tissue paper excellent in “moistness” and “smoothness”. [Solution] The problem can be solved by tissue paper being two-ply tissue paper, in which a basis weight per one ply is greater than 12.9 g/m2 and less than 16.8 g/m2, a paper thickness in the two-ply state is not less than 128 ?m nor more than 150 ?m, and a chemical agent containing glycerin and 1,3-propanediol in a total amount of 83.7 mass % or more and having a mass ratio between glycerin and 1,3-propanediol of greater than 1:0.14 and less than 1:6.64, is contained in an amount of greater than 2.3 g/m2 and less than 6.1 g/m2.

Abstract: The current invention discloses a treatment device having a heat source, a power source, a heat applicator and a lighting mechanism. The power source includes at least one battery having superior properties such as prolonged electricity production and prompt recharging. The heat applicator includes a heat conductive layer made from nanofibers, providing highly efficient heat distribution to the targeted regions. The lighting mechanism employs light emitting nano fibers to treat targeted regions. The power source provides energy to the light source, which generates light so that the applicator may distribute to an injury site or wound bed of a user. The heat source may be an exothermic chemical reaction designed to last for several hours supplying heat to the treatment device or an electronically produced heat. The treatment device further comprises a plurality of electrodes for electrical stimulation treatment.

Abstract: Described herein is/are cold foil adhesive methods for manufacturing temporary tattoo laminate devices, wherein the tattoos incorporate metallic foil and other decorative components. The methods provide a surprisingly rapid and efficient method for creating tattoo laminate devices which provide crisp, clear multi-color images temporary tattoos for the skin. The methods described herein provide a way to produce, in an offset printing press or flexographic printing press, numerous tattoo laminate devices at very high speeds, with unlimited colors, and crisp, clear images.

Abstract: An absorbent article includes a liquid-permeable top sheet, a liquid-impermeable back sheet, and an absorbent body between the liquid-permeable top sheet and liquid-impermeable back sheet. The liquid-permeable top sheet includes a blood modifying agent with an IOB of 0.00-0.60, a melting point of no higher than 45° C., a water solubility of 0.00-0.05 g in 100 g of water at 25° C., and a weight-average molecular weight of no greater than 1,000.

Abstract: A method of delivering a health care active having the steps of administering to a mammal in need of a health benefit or a treatment for a health condition a personal health care article and consuming the article. The article contains one or more filaments that contain a backbone material, a health care active and optionally aesthetic agents, extensional aids, plasticizers, and crosslinking agents.

Abstract: A maternity or postpartum support-garment that includes at least one of a stretchable and/or compressive material, at least one generally cylindrical shaped upper portions, and at least one generally cylindrical shaped base portions is provided. The maternity or postpartum support garment may further include at least one ribbing sections located on at least one of the one or more generally cylindrical shaped upper portions or base portions. The at least one ribbing section may include a first level of compression. The first section may include a different level of compression than the at least one ribbing section.

Abstract: A method of delivering a health care active having the steps of administering to a mammal in need of a health benefit or a treatment for a health condition a personal health care article and consuming the article. The article contains one or more filaments that contain a backbone material, a health care active and optionally aesthetic agents, extensional aids, plasticizers, and crosslinking agents.

Abstract: Disclosed are compositions for treating and cleansing keratinous substrates, comprising: a polysaccharide; a cationic polymer in an amount of at least 0.1% by weight based on the total weight of the composition; an anionic surfactant chosen from sulfonate surfactants, carboxylic (carboxylate) surfactants, and mixtures thereof; a polyol; and a cosmetically acceptable carrier. The compositions can additionally contain a glyceryl ester. Also, the compositions have a gel or semi-solid structure and texture. Disclosed are methods of treating and cleansing keratinous substrates using the compositions of the invention.

Abstract: The present invention relates to a method for producing a functional yarn, in which zirconium phosphate having a multiple-layered structure is used as a deodorizing material and a melted polymer is spun through a spinning nozzle having a multi-lobal sectional shape. According to the present invention, the melted polymer contains layered fine zirconium phosphate inorganic particles having low hardness, and thus the abrasion of production process equipment can be minimized during fiber production and also an excellent deodorizing property and an excellent sweat-absorbing and quick-drying property are exhibited.

Abstract: A biocide-free sponge cloth prewetted with a hygroscopically acting inorganic salt is provided. The spone cloth is based on regenerated cellulose which is mechanically reinforced with fibers and/or a web and includes a hygroscopically acting salt. The sponge cloth has an aw value of less than 0.80. On account of the low aw value, the sponge cloth has an antibacterial, bacteriostatic, fungicidal and/or fungistatic effect. The hygroscopically acting salt is preferably magnesium chloride. It can be combined with further inorganic salts, with low molecular weight, mono- or polyhydric alcohols, with sugars, sugar esters, mono- or polybasic carboxylic acids, esters of mono- or polybasic carboxylic acids and/or with hydrophilic polymers. The sponge cloth is preferably produced by the viscose process.

Abstract: A liquid excipient is added to a lock solution formulation containing a lower alcohol and an anti-coagulant, antibiotic, and/or anti-microbial, such as the ethanol and tri-sodium citrate lock solution formulation, to prevent citrate from crystallizing in catheters made from silicone. The locking solution could include a liquid excipient, such as glycerol, polysorbate-20, or polyethylene glycol (PEG)-400, along with a lower alcohol, such as ethanol, and an anti-coagulant, such as tri-sodium citrate, antibiotic, and/or anti-microbial.

Abstract: The present disclosure provides a sterilized chlorhexidine product that comprises a package and a sterilized chlorhexidine article. The package defines an interior volume. The sterilized chlorhexidine article comprises a sterilized applicator and a sterilized antiseptic composition. The sterilized antiseptic composition comprises a sterilized solvent and a sterilized antibacterial agent dissolved in the solvent. The sterilized chlorhexidine article is disposed in the internal volume of the package. The sterilized chlorhexidine article has a Sterility Assurance Level of from 10?3 to 10?9. The present disclosure also provides a method for sterilizing the chlorhexidine article.

Abstract: Disclosed herein is a structure having: a porous polymeric film permeated by a first extracellular matrix material; and a topcoat layer comprising a second extracellular matrix gel disposed on the film. Also disclosed herein is a method of: providing a porous polymeric film; permeating the film with a first extracellular matrix material; and applying a topcoat layer of a second extracellular matrix material to the film. Also disclosed herein is a method of: laser-machining holes through a film comprising collagen to form a web-like structure.

Abstract: The current invention aims to absorb sweat and body odor from the breasts. It also protects the skin by providing a cushioned support strip below the bra wire. The invention is a lining to be affixed between the inner lining of a brassiere and the skin, having three layers and a set of flaps protruding from the device adapted to be folded outward to hold the device in place.

Abstract: Methods and apparatus to form biocompatible energization elements are described. In some examples, the methods and apparatus to form the biocompatible energization elements involve forming cavities composing active cathode chemistry. The active elements of the cathode and anode are sealed with a biocompatible material. In some examples, a field of use for the methods and apparatus may include any biocompatible device or product that requires energization elements.

Abstract: A simple disposable absorbent article including a chassis and an absorbent assembly. The chassis includes a water-impermeable sheet folded laterally inward at both of its side edges to form opposing side flaps. Each side flap is attached to the interior surface of the chassis adjacent to its end edges. Each side flap has a longitudinally extending elastic gathering member attached adjacent to its proximal edge. The absorbent assembly is smaller in width and in length than the chassis. The side edges and end edges of the absorbent assembly may be disposed proximally relative to the respective side edges and end edges of the chassis. The absorbent assembly includes an absorbent core that may contain superabsorbent particles, which may be contained inside pockets. The chassis may be extensible. The absorbent assembly may be in a cruciform pattern to the chassis to allow portions of the chassis to extend laterally.

Abstract: An enhanced, co-formed fibrous web structure is disclosed. The web structure may have a co-formed core layer sandwiched between two scrim layers. The core layer may be formed of a blend of cellulose pulp fibers and melt spun filaments. The scrim layers may be formed of melt spun filaments. Filaments of one or both of the scrim layers, and optionally the core layer, may also be meltblown filaments. The fibrous web structure may have a Consumer Preference Indication (governing allocation of melt spun filaments between core layer and scrim layers) greater than 0. Alternatively, the filaments forming the scrim layers may constitute from 1 to 13 percent of the weight of the structure. Alternatively, the scrim layers may have a combined basis weight of from 0.1 gsm to less than 3.0 gsm. A method for forming the structure, including direct formation of layers, is also disclosed.

Abstract: The present disclosure relates to a fiber suitable for packaging. The fiber of the present disclosure comprises a photocatalyst bonded to it by means of a first functional group generated by a surface modifying agent and optionally, a second functional group generated by a silicon containing linker. The chemical bonding between the fiber and the photocatalyst imparts durability and wash ability to the fiber. A packaging material prepared using the fiber of the present disclosure can be used for the storage of plant produce.

Abstract: A nanostructured biocompatible wafer for placement in the conjunctival cul-de-sac. The wafer contains a tissue-reactive mucoadhesive polymer and a mesh formed of a plurality of hydrophobic polymer fibers. Also provided is a method for treating glaucoma, an ocular surface disorder, or an ocular surface infection using the nanostructured biocompatible wafer. Additionally, an injectable sustained-release formulation for treating an ocular disorder is disclosed. The formulation includes a drug contained within a plurality of microparticles formed of a biodegradable polymer and are coated with a tissue-reactive compound. Further provided is a method for treating an ocular disorder by injecting the microparticulate sustained release formulation.

Abstract: The present invention generally relates to a wet wipe or sheet that is suitable for contacting the skin and removing mucus from the skin. More specifically, the present invention relates to a wet wipe having an aqueous saline component suitable for dissolving and removing mucus in combination with the fabric matrix of the wet wipe. Typically, the fabric matrix of the wet wipe has a capacity of about 125 grams of solution per square meter, and it is impregnated with the aqueous saline solution to a level at or below approximately 80% of the absorbent capacity of the matrix.

Abstract: A medical bandage is provided, capable of being rapidly, adjustably, intuitively and universally fitted on a head, limb or stump, for instance to conceal and protect a wound. The medical bandage is cap-shaped, and is formed of several layers, and comprised at least one port for obtaining quick access to a wound concealed by the medical bandage. When open, a port can stabilize a drainage tube, or provide a passage through which to easily and rapidly apply a medicine. The medical bandage can be directly fit on the head or other body part, providing an all-in-one dressing, wrap and treatment, and eliminating the need for cumbersome and difficult to manage gauze roll and multiple bandages of various sizes, shapes, and uses. The medical bandage provides simple, rapid, and effective treatment of emergency trauma wounds, and improved medical treatment of acute or chronic wounds.

Abstract: Methods and apparatus to form biocompatible energization elements are described. In some examples, the methods and apparatus to form the biocompatible energization elements involve forming cavities composing active cathode chemistry. The active elements of the cathode and anode are sealed with a biocompatible material. In some examples, a field of use for the methods and apparatus may include any biocompatible device or product that requires energization elements.

Abstract: A polymer with antibacterial activity is provided. The polymer has multiple groups of cationic amines, each group spaced from the polymer backbone by alkylene spacers of different lengths. The resulting polymer maintains significant antibacterial activity while having reduced hemolytic activity relative to a homopolymer that uses hexylene spacers.

Abstract: The present invention generally relates to absorbent sanitary articles for absorption of body fluids and in particular to a sanitary article of this type including a buffer composition adapted to adjust the natural pH of the absorbed body fluid to a pH that is compatible with the pH of skin.

Abstract: A virucidal disinfectant or antiseptic is disclosed comprising 45-65 wt % of at least one alcohol, and 0.05-0.5 wt % of at least one phosphonate. The pH should be adjusted to lie between 3 and 10. Such disinfectant/antiseptic can be used for disinfecting a living or a non-living object and exhibits activity against a broad range of microorganisms such as viruses, fungi and/or bacteria, in particular against naked viruses such as polio.

Abstract: Present invention related to method of washing and finishing leather, canvas, cotton and any other material, as well as the finished products such as, but not limited to shoes, bags, accessories, clothing, denim, T-Shirts, and components of these products by washing in brewed coffee. Material, for example leather, canvas, cotton, denim, washed in coffee before manufacturing the product.

Abstract: The current invention discloses a treatment device having a heat source, a power source, a heat applicator and a lighting mechanism. The power source includes at least one nanotech battery, ensuring superior properties such as prolonged electricity production and prompt recharging. The heat applicator includes a heat conductive layer made from nanofibers, providing highly efficient heat distribution to the targeted regions. The lighting mechanism employs light emitting nano fibers to treat targeted regions. The power source provides energy to the light source, which generates light so that the applicator may distribute to an injury site or wound bed of a user. The heat source may be an exothermic chemical reaction designed to last for several hours supplying heat to the treatment device or a electronically produced heat. In addition to the medical utilizations, the current device may also play a central role in other apparatus that require thermal control or lighting capabilities.

Abstract: An absorbent article, such as a catamenial device, having a liquid pervious topsheet, a backsheet joined to the topsheet, and an absorbent core disposed between the topsheet and the backsheet is disclosed. The absorbent article has a lotion composition applied to at least a portion of the outer surface of the topsheet, the lotion composition including a rheology structurant selected from the group consisting of microcrystalline wax, alkyl dimethicone, ethylene glycol dibehenate, ethylene glycol distearate, glycerol tribehenate, glycerol tristearate, and ethylene bisoleamide.

Abstract: The present invention relates to a process for the production of a multi-layered material having anisotropic pores. It further relates to a multi-layered material which can be produced by the process according to the invention, and to the use of a multi-layered material as a chondral support matrix, a meniscus support matrix or an intervertebral disc support matrix.

Abstract: A bone repair composition and methods thereof include elongated bone fibers made from cortical bone in which a plurality of approximately uniform bone fibers is made into various implant shapes conducive for various applications. The bone fiber compositions may be in the form of a cavity, ball, pellet, wrap, strip, cylinder, cone, putty, gel, or injectable slurry.

Abstract: The present invention relates to a method of cosmetic care that consists of applying, on at least one area of the body, a cosmetic composition containing an elastic mixture consisting of at least one starch, at least one polymer selected from polyvinyl alcohols, vinylpyrrolidone polymers and copolymers and latex, at least one polyol, and optionally water. The mixture imparts elasticity to the cosmetic product applied on the surface of the skin naturally subjected to deformations, such as the changes of facial expression, pressure of the fingers by contact, or contact with clothing.

Abstract: A package of diapers is provided for treating diaper rash, where the package of diapers includes a first diaper and a second diaper. The first diaper includes an absorbent layer configured to absorb moisture away from a wearer of the first diaper and a topical layer applied on the absorbent layer of the first diaper in a first pattern. The second diaper includes an absorbent layer configured to absorb moisture away from a wearer of the second diaper and a topical layer applied of the absorbent layer of the second diaper in a second pattern, where the first pattern is different than the second pattern.